Rachel Haurwitz | |
---|---|
![]() Haurwitz in 2019 | |
Born | Rachel Elizabeth Haurwitz May 20, 1985 Austin, Texas, U.S. |
Alma mater |
|
Scientific career | |
Fields | Biochemistry |
Institutions | Caribou Biosciences |
Thesis | The CRISPR endoribonuclease Csy4 utilizes unusual sequence- and structure-specific mechanisms to recognize and process crRNAs (2012) |
Doctoral advisor | Jennifer Doudna |
Rachel Elizabeth Haurwitz (born May 20, 1985) is an American biochemist and structural biologist. She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.
Haurwitz was born on May 20, 1985.[ citation needed ] She grew up in Austin, Texas. [1] Her mother is an elementary school teacher and her father, an environmental journalist. [2]
Haurwitz began researching RNA during her undergraduate years. [3] She attended Harvard College where she earned an undergraduate degree. In 2007, she began doctoral studies at University of California, Berkeley. At the age of 21, [4] Haurwitz began working as a graduate student in Jennifer Doudna's laboratory, in 2008 where she completed her doctorate in molecular and cell biology. [5] Haurwitz originally intended on becoming an intellectual property lawyer for biotechnology patents but later chose to continue in science. [6]
In 2011, Haurwitz and Doudna co-founded Caribou Biosciences, a gene editing spinout-startup company. [7] Haurwitz is the company's CEO and president. She holds several patents for CRISPR-based technologies. [5] The firm was initially housed in the basement of the building that housed Doudna's laboratory. The company supports the commercialization [8] of CRISPR technology in healthcare and agriculture. [9] Its researchers explore issues in antimicrobial resistance, food scarcity, and vaccine shortages. [9] The company licensed Berkeley's CRISPR patent and deals with agricultural and pharmaceutical companies and research firms. [10] In 2018, Haurwitz announced that the firm was shifting focus on medicine and developing cancer therapies targeting microbes. [2]
She is a long-distance runner and is training for a marathon. [9] Haurwitz knits as a hobby. [6]
In 2021, Haurwitz was selected as a Bloomberg New Economy Catalyst. As part of the program, she attended the annual New Economy Forum held in Singapore, and the Bloomberg New Economy Catalyst Retreat that same year. [11]